Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.770
-0.200 (-6.73%)
At close: Apr 10, 2026, 4:00 PM EDT
2.720
-0.050 (-1.81%)
After-hours: Apr 10, 2026, 7:47 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $7.37 million as of April 10, 2026. Its market cap has increased by 250.87% in one year.
Market Cap
7.37M
Enterprise Value
1.83M
1-Year Change
250.87%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $7.37M, a decrease of -78.58%. That is a compound annual growth rate of -24.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 7.40M | 13.85% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 7.59M |
| TransCode Therapeutics | 7.53M |
| Acurx Pharmaceuticals | 7.45M |
| Aptorum Group | 7.41M |
| BioAtla | 7.39M |
| MetaVia | 7.18M |
| Silo Pharma | 7.17M |
| GridAI Technologies | 7.03M |